Lung Cancer News and Research

Latest Lung Cancer News and Research

Research shows different EML4-ALK variants drive lung cancer aggressiveness

About five percent of lung adenocarcinomas, one of the most common forms of lung cancer, are driven by a faulty fusion of two genes, EML4 and ALK.

23 Sep 2025

Scheduling combined visits improves wellness care and reduces no shows

A recurrent barrier to Medicare annual wellness visits, which provide preventative medicine guidance for older and disabled patients, occurs when patients introduce medical concerns to physicians during these preventative visits.

23 Sep 2025

Study identifies immune biomarkers for personalized therapies in pediatric germ cell tumors

A study conducted by the Molecular Oncology Research Center (CPOM) at Hospital de Amor in Barretos (formerly Barretos Cancer Hospital) in the state of São Paulo, Brazil, has identified possible biomarkers that could guide the development of more personalized therapies for pediatric germ cell tumors (GCTs).

18 Sep 2025

Digital twin of lung cancer cell offers new insights into tumor growth and treatment

An enhanced computer model is now helping to provide fresh insights into cancer-cell growth and how it can be stopped. The digital cell model represents another step towards individualized cancer treatment.

18 Sep 2025

New molecule offers a more targeted and potent immunotherapy

A newly developed molecule brings together two powerful immunotherapy strategies in one treatment. Researchers at the University of Basel and University Hospital Basel, Switzerland, have demonstrated that this fusion protein can both block the "do not attack" signal used by cancer cells and selectively activate tumor-fighting immune cells. This dual action could pave the way for more effective cancer therapies with fewer side effects.

18 Sep 2025

The 15th AACR cancer progress report highlights scientific advances

The American Association for Cancer Research (AACR) released the 15th edition of its annual Cancer Progress Report. A cornerstone of the AACR's educational and advocacy efforts, this comprehensive report provides the latest statistics on cancer incidence, mortality, and survivorship and highlights how federal investments in basic, translational, and clinical cancer research and cancer-related population sciences have led to impressive scientific advances that are improving health and saving lives.

17 Sep 2025

CRISPR-GPT helps scientists to generate designs, analyze data and troubleshoot design flaws

Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing experiments.

16 Sep 2025

Deep learning tool improves accuracy of lung nodule malignancy detection

An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive results.

16 Sep 2025

Machine learning models can predict urgent care needs for patients with non–small cell lung cancer

A new study published in JCO Clinical Cancer Informatics demonstrates that machine learning models incorporating patient-reported outcomes and wearable sensor data can predict which patients with non–small cell lung cancer are most at risk of needing urgent care during treatment.

16 Sep 2025

PM2.5 pollution linked to lung cancer shows sharp declines in the U.S. but not in China

The study highlights the need for stronger air quality measures as global lung cancer deaths linked to pollution are projected to rise, especially in China.

16 Sep 2025

Researchers reveal why global gains against chronic diseases are stalling

Researchers analysed mortality data from 185 countries and found that while global non-communicable disease (NCD) deaths before age 80 declined from 2010 to 2019, progress slowed compared to 2001–2010. Gains were mainly from drops in heart disease and stroke, but rising burdens from diabetes, cancers, and neuropsychiatric conditions stalled momentum.

15 Sep 2025

AI rollout in NHS hospitals faces major challenges

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools and staff training, finds a major new UK study led by UCL researchers.

10 Sep 2025

Lung tumors rewire immune cells in the bone marrow before they reach cancer sites

Lung tumors don't just evade the immune system. They reshape it at its source. Researchers from the Icahn School of Medicine at Mount Sinai and collaborators report in the September 10 online issue of Nature that tumors rewire immune cells in the bone marrow before they even reach the cancer, suggesting a new target to enhance the durability of current immunotherapy

10 Sep 2025

New AI model can identify treatments that reverse disease states in cells

In a move that could reshape drug discovery, researchers at Harvard Medical School have designed an artificial intelligence model capable of identifying treatments that reverse disease states in cells.

10 Sep 2025

Subcutaneous amivantamab plus lazertinib yields high response in EGFR-mutant lung cancer

A new analysis from the PALOMA-2 study presented today shows that subcutaneous administration of amivantamab every four weeks (Q4W), in combination with daily oral lazertinib, yields a high objective response rate in patients with previously untreated EGFR-mutated advanced non-small cell lung cancer (NSCLC).

10 Sep 2025

Emphysema detected on CT predicts mortality from all causes

Emphysema detected on baseline low-dose chest CT (LDCT) in the lung cancer screening cohort of more than 9,000 asymptomatic adults was associated with death from all causes, chronic obstructive pulmonary disease (COPD), and cardiovascular disease within a 25-year follow-up period in a new study published today in Radiology, a journal of the Radiological Society of North America.

10 Sep 2025

Combination immunotherapy prior to surgery shows encouraging results in mesothelioma

Results from an early phase clinical trial presented this week at the World Conference on Lung Cancer Meeting in Barcelona, Spain, and published in the Nature Medicine journal today [Monday, 8th September 2025] show that patients with mesothelioma - a rare cancer of the lining of the lung that may be caused by exposure to asbestos - who received a combination of two immunotherapy drugs, nivolumab and ipilimumab, before surgery had successful surgeries and encouraging early outcomes.

9 Sep 2025

Researchers reveal why no level of air pollution is safe for respiratory health

A review in the Journal of Clinical Investigation shows how particulate matter damages the lungs through oxidative stress, inflammation, and immune disruption. It links air pollution to asthma, COPD, lung cancer, infections, and millions of premature deaths, with no safe exposure threshold.

9 Sep 2025

Planetary health diet links to longer life and lower emissions

Greater adherence to the Planetary Health Diet was linked to lower all-cause, cancer, and respiratory mortality across large US and UK cohorts, supported by a meta-analysis of 37 studies. Diets higher in PHD foods also had smaller greenhouse gas footprints, reinforcing health and environmental benefits.

9 Sep 2025

IFITM3 found to be critical regulator of immunotherapy sensitivity in small cell lung cancer

New research presented identifies interferon-induced transmembrane protein 3 (IFITM3) as a critical regulator of immunotherapy sensitivity in small cell lung cancer (SCLC), offering a promising new avenue for overcoming resistance to PD-1/PD-L1 checkpoint blockade.

9 Sep 2025

Lung Cancer News and Research

Latest Lung Cancer News and Research

Research shows different EML4-ALK variants drive lung cancer aggressiveness

Scheduling combined visits improves wellness care and reduces no shows

Study identifies immune biomarkers for personalized therapies in pediatric germ cell tumors

Digital twin of lung cancer cell offers new insights into tumor growth and treatment

New molecule offers a more targeted and potent immunotherapy

The 15th AACR cancer progress report highlights scientific advances

CRISPR-GPT helps scientists to generate designs, analyze data and troubleshoot design flaws

Deep learning tool improves accuracy of lung nodule malignancy detection

Machine learning models can predict urgent care needs for patients with non–small cell lung cancer

PM2.5 pollution linked to lung cancer shows sharp declines in the U.S. but not in China

Researchers reveal why global gains against chronic diseases are stalling

AI rollout in NHS hospitals faces major challenges

Lung tumors rewire immune cells in the bone marrow before they reach cancer sites

New AI model can identify treatments that reverse disease states in cells

Subcutaneous amivantamab plus lazertinib yields high response in EGFR-mutant lung cancer

Emphysema detected on CT predicts mortality from all causes

Combination immunotherapy prior to surgery shows encouraging results in mesothelioma

Researchers reveal why no level of air pollution is safe for respiratory health

Planetary health diet links to longer life and lower emissions

IFITM3 found to be critical regulator of immunotherapy sensitivity in small cell lung cancer

The ultimate guide to lung research tools and protocols eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in